| 1/7 | US=34 / Câncer Makdissi FBA, Achatz MIW. Síndrome de cânceres de mama e ovário hereditários. In: Guimarães JRQ. Manual de oncologia. 3ª ed. São Paulo: BBS Editora, 2008. p. 137-42. GENES BCRA1 E BCRA2; TRATAMMENTOS PROFILATICOS; QUIMIOPROFILAXIA; INIBIDORES DE AROMATASE; CIRURGIA PROFILATICA; OOFORETOMIA PROFILATICA |
| 2/7 | US=22 / Câncer Brenner DE. Drugs for chemoprevention. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 626-35. MEDICAMENTOS ANTI INFLAMATORIOS; ANTI-INFECCAO; HELICOBACTER PYLORI; SELECAO DE ESTROGEN RECEPTORES MODULADORES; INIBIDORES DE AROMATASE; SINAIS DE TRANSDUCAO MODIFICADA; EFLORNITINA; RECEPTORES E FATOR DE CRESCIMENTO |
| 3/7 | US=23 / Câncer McCubrey JA, Franklin RA, Navolanic PM, Martelli AM, Steelman LS. Chemotherapy for breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 319-25. ISBN 978-1-4020-8368-6. CANCER DE MAMA; QUIMIOTERAPIA; METOTREXATO; 5-FLUOROURACIL; CICLOFOSFAMIDA; ANTRACICLINA; TAXANOS; TRASTUZUMABE; TAMOXIFENO; INIBIDORES DE AROMATASE |
| 4/7 | US=23 / Câncer Benson JR, Turner EH, Winters Z. Breast cancer: side effects of tamoxifen and anastrozole. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 433-57. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TAMOXIFENO; ANASTROZOL; TERAPIA ANTI-HORMONAL; CANCER DE MAMA AVANCADO; TERAPIA HORMONAL NEOADJUVANTE; TERAPIA HORMONAL ADJUVANTE; QUIMIOPREVENCAO; INIBIDORES DE AROMATASE |
| 5/7 | US=47 / Clín/Medica Hong Y, Chen S. Aromatase inhibitors: structural features and biochemical characterization. In: Bradlow KL, Carruba G. Estrogens and human diseases. Boston: Blackwell, 2006. p. 237-51. ISBN 978-1-57331-699-5. INIBIDORES DA AROMATASE; CANCER DE MAMA; INIBIDORES DE AROMATASE; FLAVONOIDE FITOESTROGENO; INIBIDOR BASEADO NO MECANISMO; MODELO STRCTURAL |
| 6/7 | US=61 / Câncer osipo C, O'Regan RM. The role of hormones, growth factors, and oncogenes: resistance to antiestrogens. In: Teicher BA. Cancer drug resistance. New Jersey: Humana Press, 2006. p. 411-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-530-1. ANTIESTROGENEO; RESISTENCIA; TAMOXIFEN; CANCER DE MAMA; RECEPTOR DE ESTROGENO; INIBIDORES DE AROMATASE; FACTORES DE CRESCIMENTO |
| 7/7 | US=22-C / Câncer Goetz MP, Erlichman C, Loprinzi CL, Kohli M. Agentes hormonais. In: DeVita VT, Lawrence TS, Rosenberg SA. DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. 10 ed. Philadelphia: Wolters Kluwer, 2015. p. 278-289. ISBN 978-1-45119294-0. MODULADORES SELETIVOS DO RECEPTOR DE ESTROGENIO; INIBIDORES DE AROMATASE; HORMONIO LIBERADOR DE GONADOTROPINA. ANALOGOS; HORMONIO LIBERADOR DE GONADOTROPINA. ANTAGONISTAS; ANTIANDROGENO; ESTEROIDES SEXUAIS. TERAPIAS; OUTRAS TERAPIAS HORMONAIS |